+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics



Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics



Psychiatry and Clinical Neurosciences 58(3): 268-273



Many studies have demonstrated that atypical antipsychotics are superior to typical antipsychotics in that they have fewer side-effects and produce better improvement of cognitive deficits and quality of life in patients with schizophrenia. However, most of these studies dealt with objective indices assessed by researchers rather than subjective indices that are indeed important to patients themselves. In 126 patients with schizophrenia, annoyance of side-effects and psychotic symptoms, satisfaction with medication, wish to change medication, and knowledge of atypical antipsychotics were assessed using questionnaires. Patients treated with typical antipsychotics complained less of annoyance of poor attention and concentration than those treated with atypical antipsychotics, which can be explained by increased awareness of these symptoms by the patients due to the improvement of cognitive function. There were no significant differences between the two groups in other variables. The present results that satisfaction and annoyance were similar between patients treated with typical antipsychotics and those with atypical antipsychotics, may partly explain why patients hesitated and rejected changing or shifting from typical to atypical antipsychotics. But because 98 of 126 patients did not know about atypical antipsychotics, it is important to educate the patients on the merits of atypical antipsychotics.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048786707

Download citation: RISBibTeXText

PMID: 15149292

DOI: 10.1111/j.1440-1819.2004.01230.x


Related references

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study. Iranian Journal of Psychiatry and Behavioral Sciences 8(1): 66-71, 2014

Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. Psychiatry Research 144(2-3): 177-189, 2006

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of General Psychiatry 16: 43, 2017

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. American Journal of Psychiatry 160(2): 290-296, 2003

Visuo-perceptual processing in patients with schizophrenia treated with typical or atypical antipsychotics. Actas Espanolas de Psiquiatria 29(1): 19-24, 2001

Atypical antipsychotics not associated with improved hospitalisation outcomes compared with typical antipsychotics in people with schizophrenia in real practice. Evidence-BasedMentalHealth16(2):36, 2013

Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics. Neuropsychiatric Disease and Treatment 4(1): 289-294, 2008

A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. International Journal of Neuropsychopharmacology 10(4): 463-477, 2007

Frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia treated with atypical and typical antipsychotics. Human Physiology 40(1): 35-39, 2014

Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals. European Neuropsychopharmacology 16(6): 429-436, 2006

Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia. Journal of Clinical Psychopharmacology 33(3): 319-328, 2013

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophrenia Research 81(2-3): 291-300, 2006

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand. Clinicoeconomics and Outcomes Research 8: 127-136, 2016

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia. Patient Preference and Adherence 2: 67-77, 2008

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. Journal of Clinical Psychopharmacology 22(4): 359-365, 2002